Paper8634249
Modulation of functional properties of galectin-3 by monoclonal antibodies binding to the non-lectin domains.
Liu FT and 6 others. Biochemistry, 1996. Cited by 79 papers, by iCite.
Cite this record
ConductScience Library. Modulation of functional properties of galectin-3 by monoclonal antibodies binding to the non-lectin domains. Papers, record 8634249. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8634249
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Modulation of functional properties of galectin-3 by monoclonal antibodies binding to the non-lectin domains.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Antigens, Differentiation | Major topic |
| Binding Sites, Antibody | Major topic |
| Animals | |
| Base Sequence | |
| Cell Membrane | |
| DNA Primers | |
| Epitopes | |
| Galectin 3 | |
| Hemagglutination Tests | |
| Humans | |
| Immunoglobulin E | |
| Lectins | |
| Mice | |
| Mice, Inbred BALB C | |
| Molecular Sequence Data | |
| Neutrophils |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 5T32 AR07144 | NIAMS NIH HHS | United States | T32AR007144 | PubMed and NIH | NIH RePORTER |
| AI20958 | NIAID NIH HHS | United States | R01AI020958 | PubMed and NIH | NIH RePORTER |
| MO1RR00833 | NCRR NIH HHS | United States | M01RR000833 | PubMed and NIH | NIH RePORTER |
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40686614 | Prevalence and risk factors for asymptomatic venous thromboembolism in patients with primary brain tumors. | iScience | 2025 | https://conductscience.org/library/papers/40686614 | PubMed |
| 39211619 | CH-π Interactions Are Required for Human Galectin-3 Function. | JACS Au | 2024 | https://conductscience.org/library/papers/39211619 | PubMed |
| 37988169 | Galectin-3 aggravates microglial activation and tau transmission in tauopathy. | J Clin Invest | 2024 | https://conductscience.org/library/papers/37988169 | PubMed |
| 37815932 | Galectin-3 does not interact with RNA directly. | Glycobiology | 2024 | https://conductscience.org/library/papers/37815932 | PubMed |
| 36975419 | Gal-3 Protein Expression and Localization in Prostate Tumours. | Curr Oncol | 2023 | https://conductscience.org/library/papers/36975419 | PubMed |
| 36880731 | Proteolytic regulation of a galectin-3/Lrp1 axis controls osteoclast-mediated bone resorption. | J Cell Biol | 2023 | https://conductscience.org/library/papers/36880731 | PubMed |
| 36703969 | Inhibition of galectins in cancer: Biological challenges for their clinical application. | Front Immunol | 2022 | https://conductscience.org/library/papers/36703969 | PubMed |
| 34794390 | Combined proteomic/transcriptomic signature of recurrence post-liver transplantation for hepatocellular carcinoma beyond Milan. | Clin Proteomics | 2021 | https://conductscience.org/library/papers/34794390 | PubMed |
| 34612142 | LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/α-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neurons. | Autophagy | 2022 | https://conductscience.org/library/papers/34612142 | PubMed |
| 33788185 | Galectin-3 Promotes ROS, Inflammation, and Vascular Fibrosis in Pulmonary Arterial Hypertension. | Adv Exp Med Biol | 2021 | https://conductscience.org/library/papers/33788185 | PubMed |
| 33276677 | Inter-Relationship between Platelet-Derived Microparticles and Oxidative Stress in Patients with Venous Thromboembolism. | Antioxidants (Basel) | 2020 | https://conductscience.org/library/papers/33276677 | PubMed |
| 31440233 | The Sweet-Side of Leukocytes: Galectins as Master Regulators of Neutrophil Function. | Front Immunol | 2019 | https://conductscience.org/library/papers/31440233 | PubMed |
| 31375685 | Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington's disease. | Nat Commun | 2019 | https://conductscience.org/library/papers/31375685 | PubMed |
| 30767565 | Galectin-3: A Harbinger of Reactive Oxygen Species, Fibrosis, and Inflammation in Pulmonary Arterial Hypertension. | Antioxid Redox Signal | 2019 | https://conductscience.org/library/papers/30767565 | PubMed |
| 29344292 | Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update. | Theranostics | 2018 | https://conductscience.org/library/papers/29344292 | PubMed |
| 29203271 | Concepts and advances in cancer therapeutic vulnerabilities in RAS membrane targeting. | Semin Cancer Biol | 2019 | https://conductscience.org/library/papers/29203271 | PubMed |
| 28548942 | The N-terminal tail coordinates with carbohydrate recognition domain to mediate galectin-3 induced apoptosis in T cells. | Oncotarget | 2017 | https://conductscience.org/library/papers/28548942 | PubMed |
| 25684095 | Downregulating galectin-3 inhibits proinflammatory cytokine production by human monocyte-derived dendritic cells via RNA interference. | Cell Immunol | 2015 | https://conductscience.org/library/papers/25684095 | PubMed |
| 25428218 | The role of galectin-3 and galectin-3-binding protein in venous thrombosis. | Blood | 2015 | https://conductscience.org/library/papers/25428218 | PubMed |
| 24423620 | IgE immunotherapy: a novel concept with promise for the treatment of cancer. | MAbs | 2014 | https://conductscience.org/library/papers/24423620 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IGHE | 3497 | PubTator's text mining | https://conductscience.org/library/genes/3497 | NCBI Gene |
| LGALS3 | 3958 | PubTator's text mining | https://conductscience.org/library/genes/3958 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8634249
GET https://conductscience.org/api/papers/v1/8634249/cited_by?page=2